Milnacipran Completed Phase 3 Trials for Vestibulodynia / Vulvodynia Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01304589Savella in Treatment for Provoked Vestibulodynia